Skip to main content

Table 6 Confidence limits (95%) for PPV and NPV values for simulations presented in Fig. 8. Prevalence threshold 30.0% two years after cessation of MDA. Data from 100 village simulations with 500 people per village

From: Assessing the interruption of the transmission of human helminths with mass drug administration alone: optimizing the design of cluster randomized trials

Raw data from 300 simulations

Bounce back

Transmission interruption

Totals

Test positive

1

89

90

Test negative

7

3

10

Totals

8

92

100

  

95% Confidence limits

 

Estimated value

Lower limit

Upper limit

Prevalence of interruption

0.920

0.844

0.962

Sensitivity

0.967

0.901

0.991

Specificity

0.875

0.447

0.993

Probability of simulation being either transmission interruption or bounce back

 Interruption

0.9

0.819

0.948

 Bounce back

0.1

0.052

0.180

For predicted elimination - probability of being true or false

 True positive (PPV)

0.989

0.930

0.999

 False positive

0.011

0.001

0.069

For predicted bounce back - probability of true or false

 True negative (NPV)

0.700

0.354

0.919

 False negative

0.300

0.081

0.646

Likelihood ratios

 Positive (C)

7.739

1.237

48.42

 Negative (C)

0.037

0.012

0.117

 Positive (W)

89.000

12.673

625.03

 Negative (W)

0.428

0.153

1.201

  1. Abbreviations: C conventional, W weighted by prevalence